CRBP
Corbus Pharmaceuticals Holding
NASDAQ: CRBP · HEALTHCARE · BIOTECHNOLOGY
$9.82
+0.00% today
Updated 2026-04-29
Market cap
$178.43M
P/E ratio
—
P/S ratio
169.88x
EPS (TTM)
$-5.90
Dividend yield
—
52W range
$6 – $21
Volume
0.2M
Corbus Pharmaceuticals Holding (CRBP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $648382.00 | $1.91M | $2.44M | $4.82M | $36.14M | $3.94M | $881705.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | +194.8% | +27.7% | +97.6% | +649.5% | -89.1% | -77.6% | -100.0% | — | — | — |
| Cost of revenue | — | — | $1.26M | $5.89M | $15.44M | $26.04M | $48.61M | $89.60M | $98267.00 | $1.64M | $1.49M | $31.17M | $600000.00 | $233000.00 |
| Gross profit | — | — | $-1.26M | $-5.24M | $-13.53M | $-23.60M | $-43.79M | $-53.46M | $3.94M | $-757527.00 | $-1.49M | $-31.17M | $-600000.00 | $-233000.00 |
| Gross margin | — | — | — | -808.2% | -707.6% | -967.1% | -908.1% | -147.9% | 100.0% | -85.9% | — | — | — | — |
| R&D | $575.00 | $210670.00 | $1.26M | $5.89M | $15.44M | $26.04M | $48.61M | $89.60M | $98.27M | $36.45M | $16.14M | $31.17M | $32.22M | $70.09M |
| SG&A | $289.00 | $346606.00 | $1.39M | $3.61M | $6.46M | $8.96M | $12.96M | $23.64M | $28.48M | $20.43M | $18.70M | $13.91M | $16.50M | $15.21M |
| Operating income | $-824.00 | $-557276.00 | $-2.65M | $-8.85M | $-19.99M | $-32.56M | $-56.75M | $-77.10M | $-122.81M | $-55.99M | $-34.84M | $-45.08M | $-48.72M | $-85.31M |
| Operating margin | — | — | — | -1365.5% | -1045.6% | -1334.4% | -1176.8% | -213.3% | -3119.2% | -6350.1% | — | — | — | — |
| EBITDA | $-62.00 | $-556522.00 | $-2.64M | $-8.81M | $-19.90M | $-32.31M | $-56.25M | $-76.37M | $-121.12M | $-54.35M | $-38.73M | $-40.10M | $-37.74M | $-85.08M |
| EBITDA margin | — | — | — | -1358.7% | -1041.0% | -1324.0% | -1166.5% | -211.3% | -3076.2% | -6164.2% | — | — | — | — |
| EBIT | $-886.00 | $-557276.00 | $-2.65M | $-8.85M | $-19.99M | $-32.56M | $-56.75M | $-77.10M | $-122.81M | $-55.99M | $-40.21M | $-40.75M | $-38.34M | $-85.31M |
| Interest expense | — | $45114.00 | $24021.00 | $2440.00 | $0.00 | $183112.00 | $0.00 | $19025.00 | $1.03M | $1.83M | $2.13M | $2.92M | $1.87M | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-886.00 | $-602350.00 | $-2.54M | $-8.85M | $-20.00M | $-32.42M | $-55.67M | $-71.45M | $-111.27M | $-45.55M | $-55.83M | $-44.60M | $-40.21M | $-78.54M |
| Net income growth (YoY) | — | -67885.3% | -321.8% | -248.4% | -126.0% | -62.1% | -71.7% | -28.3% | -55.7% | +59.1% | -22.6% | +20.1% | +9.9% | -95.3% |
| Profit margin | — | — | — | -1365.1% | -1046.3% | -1328.6% | -1154.5% | -197.7% | -2826.1% | -5166.4% | — | — | — | — |